rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Catherine Mazzacco

Director

Company insider

Files Form 4 as: Director, Krystal Biotech; Director, Sight Sciences.

In numbers

Trades disclosed
14
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
31 Mar 2023
Last trade
14 Sep 2026
Last filed
16 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
KRYS Krystal BiotechDirector · Biotechnology · last 14 Sep 20260 buys · 0 sells
SGHT Sight SciencesDirector · Medical Devices · last 4 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
14 Sep 2026filed 16 Sep 2026KRYS Krystal Biotechoption or derivative · BiotechnologySEC FORM 4 Code A—1,187 at $0.00filing
14 Sep 2026filed 16 Sep 2026KRYS Krystal Biotechoption or derivative · BiotechnologySEC FORM 4 Code A—471 at $0.00filing
14 Sep 2026filed 16 Sep 2026KRYS Krystal Biotechoption or derivative · BiotechnologySEC FORM 4 Code A—1,187 at $0.00filing
14 Sep 2026filed 16 Sep 2026KRYS Krystal Biotechoption or derivative · BiotechnologySEC FORM 4 Code A—471 at $0.00filing
4 Jun 2026filed 5 Jun 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A—28,261 at $0.00filing
4 Jun 2026filed 5 Jun 2026SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A—28,261 at $0.00filing
11 Sep 2025filed 15 Sep 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Code G—37,492 at $0.00filing
30 Jun 2025filed 30 Jun 2025KRYS Krystal Biotechoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
5 Jun 2025filed 10 Jun 2025SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A—30,952 at $0.00filing
30 Jun 2024filed 1 Jul 2024KRYS Krystal Biotechoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
6 Jun 2024filed 10 Jun 2024SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A—17,366 at $0.00filing
30 Jun 2023filed 3 Jul 2023KRYS Krystal Biotechoption or derivative · BiotechnologySEC FORM 4 Code A—2,180 at $0.00filing
8 Jun 2023filed 3 Jul 2023SGHT Sight SciencesMedical DevicesSEC FORM 4 Code A—30,189 at $0.00filing
31 Mar 2023filed 4 Apr 2023KRYS Krystal Biotechoption or derivative · BiotechnologySEC FORM 4 Code A—13,600 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Paul BadawiPresident and CEO · President and CEO at Sight Sciences, filing Form 4 there in the last year
David BadawiChief Technology Officer · Chief Technology Officer at Sight Sciences, filing Form 4 there in the last year
Alison BauerleinChief Operating Officer · Chief Operating Officer at Sight Sciences, filing Form 4 there in the last year
Brenton TaylorEVP, Operations & R&D · EVP, Operations & R&D at Sight Sciences, filing Form 4 there in the last year
James RodbergChief Financial Officer · Chief Financial Officer at Sight Sciences, filing Form 4 there in the last year